Schrodinger Inc (SDGR) - News Archive

Schrodinger, Inc., a leader in pharmaceutical computational science, continues to make strategic moves that enhance its competitive edge in the rapidly evolving drug discovery landscape. Recent inducement grants and a s...

Schrödinger Inc. Reports New Employee Stock Grants Amid Improved Financial Ratios NEW YORK Schrödinger, Inc. (Nasdaq: SDGR) announced today the granting of restricted stock units (RSUs) as part of its ongoing strategy t...

Expanding Horizons: Ajax Therapeutics and Schrodinger Enhance Collaboration to Target New JAK Inhibitors and Drive Innovation in Cancer Research In a significant advancement for drug development, Ajax Therapeutics, Inc....

: Schrodinger, a prominent leader in the field of computational drug discovery, has announced its participation in multiple investor conferences scheduled for March 2025. This engagement presents an opportunity for the...

Schrodinger Expands Its Talent Pool with Strategic RSU Grants Under Nasdaq Listing RuleIn a notable move to bolster its workforce and align with industry standards for employee compensation, Schrodinger, Inc. (Nasdaq: S...

Schrödinger Set to Showcase Promising Preclinical Data on SGR-3515 and PRMT5-MTA at EORTC-NCI-AACR Symposium Amid Impressive Revenue Growth In an exciting development within the biopharmaceutical sector, Schrödinger Inc...